David Hong, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the promising future of cellular therapies in solid tumors, as well as some of the challenges involved, such as investigating the tumor microenvironment and the logistics of using these therapies. Dr Hong also discusses the possible solution of allogeneic cell therapy. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
